Last reviewed · How we verify

NCT06133296

Anxiety, Pain, and Quality of Life in Orthodontic Treatment

Completed NA Last updated 15 November 2023
What this trial tests

NA trial testing Conventional fixed treatment in Malocclusion in 60 participants. Completed in 1 March 2023.

Timeline
1 March 2021
Primary endpoint
1 March 2023
1 March 2023

Quick facts

Lead sponsorYuzuncu Yil University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date1 March 2021
Primary completion1 March 2023
Estimated completion1 March 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Yuzuncu Yil University

Who can join

Adults 17 to 28, any sex, with Malocclusion or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was evaluated anxiety, pain, and oral health-related quality of life in individuals treated with conventional fixed appliances (Group A) and clear aligners (Group B) for moderate malocclusion during the initial phase of orthodontic treatment

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of anxiety, pain, and quality of life in individuals with mild or moderate malocclusion between conventional fixed orthodontic treatment versus Invisalign: a randomised clinical trial.
    Tunca Y, Kaya Y, Tunca M, Keskin S. · · 2024 · cited 8× · PMID 38760747 · DOI 10.1186/s12903-024-04335-1

Verify or expand the search:

Other recruiting trials for Malocclusion

Currently open trials in the same condition.

Other Yuzuncu Yil University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06133296.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing